Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 12:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2233–2256 of 6,034 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Obesity Clear all

Conditions: Type 2 Diabetes, Overweight, Obesity
Interventions: Canagliflozin, Placebo; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity, Diabetes Mellitus, Non-Insulin-Dependent, Obesity in Diabetes
Interventions: Rimonabant (SR141716); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 1,045 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2004
U.S. locations: 45
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 39 more

Conditions: Obesity, Underweight
Interventions: Fasting-refeeding cycle; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 40 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Healthy, Adult, Calcium, Bone Resorption, Endocrine; Obesity
Interventions: Calcium carbonate, Placebo Control; Dietary Supplement
Lead sponsor: University of Georgia; Other
Eligibility: 18 Years to 45 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Athens, Georgia

Conditions: Cancer Prevention, Weight Loss, Smoldering Waldenstrom Macroglobulinemia(WM), MGUS, Fasting, Multiple Myeloma
Interventions: Prolonged Fasting Intervention, EDUCATION CONTROL; Behavioral
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity
Interventions: CP-945,598 Treatment B, CP-945,598 Treatment A, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 1,253 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 15
States / cities: Peoria, Arizona • Newport Beach, California • Miami, Florida + 12 more

Conditions: Obesity & Overweight, Obesity (Disorder)
Interventions: Positive Reinforcement, Positive Reinforcement + Areas for Change; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 127 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Endometrial Cancer, Weight Changes
Interventions: behavioral dietary intervention, counseling intervention, educational intervention, preventative dietary intervention, quality-of-life assessment; Behavioral · Other · Procedure
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years to 120 Years · Female only
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Obesity
Interventions: Fentanyl, Morphine, Dexmedetomidine; Drug
Lead sponsor: Janelle Vaughns; Other
Eligibility: 12 Years to 20 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Morbid Obesity
Interventions: Exenatide, Placebo; Drug
Lead sponsor: Advanced Specialty Care; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Bend, Oregon

Conditions: Metabolic Syndrome
Interventions: High Protein Diet, Exercise; Behavioral
Lead sponsor: University of Georgia; Other
Eligibility: 50 Years to 64 Years · Female only
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Athens, Georgia

Conditions: Overweight and Obesity
Interventions: "Eat Right Now" (ERN) mobile application; Behavioral
Lead sponsor: Brown University; Other
Eligibility: 30 Years to 55 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Obesity, Impaired Glucose Tolerance
Interventions: exenatide, Placebo; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 25 Years to 60 Years · Female only
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Metabolic Syndrome, Metabolic Endotoxemia
Interventions: MFGM-enriched full-fat dairy milk, Soy phospholipid/lecithin milk; Dietary Supplement
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Endometrioid Endometrial Adenocarcinoma
Interventions: Glucagon-like peptide 1 receptor agonist; Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Diabetes Risk
Interventions: Salsalate (4 g/day), Placebo (4 g/day); Drug
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 35 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Obesity
Interventions: high caloric intake, reduced caloric intake; Other
Lead sponsor: Temple University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Stress Hyperglycemia
Interventions: Dulaglutide Injection, Saline Injection; Drug · Other
Lead sponsor: Emory University; Other
Eligibility: 40 Years to 80 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 3
States / cities: Atlanta, Georgia

Conditions: Adiposity
Interventions: Deoxycholic Acid; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: San Diego, California

Conditions: Overweight and Obesity
Interventions: Weight-loss through dietary and lifestyle changes; Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 18 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Overweight and Obesity, Weight Loss
Interventions: Aldebaraan Nao H25; Device
Lead sponsor: Tufts University; Other
Eligibility: 25 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Physical Inactivity, Phosphate Overload, Visceral Obesity
Interventions: Sodium Phosphate, Sodium Chloride; Dietary Supplement
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 124 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Cancer Survivor, Inactivity, Obesity, Overweight, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8
Interventions: Educational Intervention, Exercise Intervention, Quality-of-Life Assessment, Questionnaire Administration; Other · Behavioral
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: 65 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Pediatric Obesity, Executive Function, Self-Regulation
Interventions: Acceptance-based Behavioral Treatment (ABBT); Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 8 Years to 12 Years
Enrollment: 184 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Birmingham, Alabama

Search by objective public record fields.

Mechanisms of Weight Loss With SGLT2 Inhibition

Obese Patients With Type 2 Diabetes

Experimental Approach to Test Predictions of Body Weight Regulation Models

Understanding Effects of Calcium on the Gut-Bone Axis

PROFAST Intervention in Precursor Multiple Myeloma

Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.

Examining Valence-based Effects in Self-Monitoring Feedback Messages

Lifestyle Change and Quality of Life in Obese Patients With Stage I/II Endometrial Cancer in Remission

Dexmedetomidine to Treat Bariatric Surgery-associated Pain

The Effects of Exenatide After Gastric Restriction

Exercise-Induced Epigenetic Modifications in Obese Aging Women

An App-based Mindfulness Intervention for Sexual Minority Women With a History of Early Life Adversities (ELA)

The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women

Alleviation Of Metabolic Endotoxemia In Adults With Metabolic Syndrome With Milk Fat Globule Membrane

A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia

Using Salsalate to Target Adipocyte Macrophage Infiltration

How Quickly Can the Effects of Excessive Caloric Intake on Insulin Resistance be Reversed?

Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients

Safety and Efficacy of Deoxycholic Acid Injection for Reduction of Upper Inner Thigh Fat

Developing a Weight Management Class as a Recruitment Tool for an Online Weight Loss Program to Rural Illinois Residents

Pilot Study on Weight Loss With Robotic Assistance

Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity

Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer Survivors

Acceptance-based Care for Child Eating and Physical Activity Treatment